- Home
- EBF vs TYRA Comparison
EBF vs TYRA Comparison
Compare EBF & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBF
- TYRA
- Stock Information
- Founded
- EBF 1909
- TYRA 2018
- Country
- EBF United States
- TYRA United States
- Employees
- EBF N/A
- TYRA N/A
- Industry
- EBF Office Equipment/Supplies/Services
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- EBF Consumer Discretionary
- TYRA Health Care
- Exchange
- EBF Nasdaq
- TYRA Nasdaq
- Market Cap
- EBF 551.3M
- TYRA 559.7M
- IPO Year
- EBF N/A
- TYRA 2021
- Fundamental
- Price
- EBF $21.57
- TYRA $10.94
- Analyst Decision
- EBF
- TYRA Strong Buy
- Analyst Count
- EBF 0
- TYRA 6
- Target Price
- EBF N/A
- TYRA $30.50
- AVG Volume (30 Days)
- EBF 156.3K
- TYRA 276.2K
- Earning Date
- EBF 04-21-2025
- TYRA 03-18-2025
- Dividend Yield
- EBF 16.22%
- TYRA N/A
- EPS Growth
- EBF N/A
- TYRA N/A
- EPS
- EBF 1.58
- TYRA N/A
- Revenue
- EBF $399,351,000.00
- TYRA N/A
- Revenue This Year
- EBF N/A
- TYRA N/A
- Revenue Next Year
- EBF N/A
- TYRA N/A
- P/E Ratio
- EBF $13.66
- TYRA N/A
- Revenue Growth
- EBF N/A
- TYRA N/A
- 52 Week Low
- EBF $18.88
- TYRA $10.65
- 52 Week High
- EBF $25.75
- TYRA $29.60
- Technical
- Relative Strength Index (RSI)
- EBF 63.06
- TYRA 29.54
- Support Level
- EBF $20.96
- TYRA $10.68
- Resistance Level
- EBF $21.40
- TYRA $11.43
- Average True Range (ATR)
- EBF 0.34
- TYRA 0.69
- MACD
- EBF 0.05
- TYRA -0.06
- Stochastic Oscillator
- EBF 91.74
- TYRA 9.24
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).